With the addition of more specialty providers and expanded services, such as clinical trials and stem cell transplants, UVA Cancer Center is making improvements to better accommodate a greater number of patients.
Category: Cancer (Page 8)
To ensure the best outcome, in terms of both disease eradication and preserving the appearance and functionality of the eye, UVA brought together skilled providers from dermatopathology, dermatologic surgery and ophthalmology.
CAR T-cell therapy was just approved by the U.S. Food and Drug Administration for commercial use in adult patients with refractory and relapsed lymphoma.
BRCA isn't the only gene mutation linked to breast cancer. With large-panel genetic testing, UVA genetic counselors can better determine who is at greatest risk.
Low-dose CT lung cancer screening has the ability to reduce lung cancer mortality by 20 percent compared to chest X-ray. Unfortunately only around 4 to 6% of people eligible for lung cancer screening are actually getting screened.
Read a case study that demonstrates the impact of the UVA-Riverside partnership as the two centers continue to provide patients in the Tidewater area and beyond access to the latest in radiosurgical technology.
Kara Romano, MD, is part of a team at UVA pioneering new radiologic approaches to treating gynecologic and other cancers.
UVA offers an updated, more conformal version of the recommended combination therapy, which includes high-dose rate brachytherapy, intensity-modulated radiation therapy and use of a prostate-rectal spacer.
UVA Cancer Center is now offering breast cancer patients a treatment that has been shown to limit hair loss. DigniCap is a scalp cooling treatment that has been FDA-approved for patients with solid tumors.
With three community oncology clinic locations, UVA Cancer Center offers advanced medical oncology and hematology care throughout the Commonwealth.